Connection
Mir Ali to Opiate Substitution Treatment
This is a "connection" page, showing publications Mir Ali has written about Opiate Substitution Treatment.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.225 |
|
|
|
-
McClellan C, Fingar KR, Ali MM, Olesiuk WJ, Mutter R, Gibson TB. Price elasticity of demand for buprenorphine/naloxone prescriptions. J Subst Abuse Treat. 2019 11; 106:4-11.
Score: 0.137
-
Jones CM, Olsen Y, Ali MM, Sherry TB, Mcaninch J, Creedon T, Juliana P, Jacobus-Kantor L, Baillieu R, Diallo MM, Thomas A, Gandotra N, Sokolowska M, Ling S, Compton W. Characteristics and Prescribing Patterns of Clinicians Waivered to Prescribe Buprenorphine for Opioid Use Disorder Before and After Release of New Practice Guidelines. JAMA Health Forum. 2023 07 07; 4(7):e231982.
Score: 0.045
-
Sanmartin MX, Ali MM, Dwyer DS. Trends in buprenorphine-waivered providers in Medicaid expansion and non-expansion states by their public listing status. Subst Abus. 2022 12; 43(1):1072-1074.
Score: 0.043